Novo Nordisk announces phase 2 clinical trial results of amycretin in people with type 2 diabetes: Bagsværd, Denmark Thursday, November 27, 2025, 13:00 Hrs [IST] Novo Nordisk, a ...

Teva Pharma receives European marketing approvals for Ponlimsi, biosimilar to Prolia and Degevma, biosimilar to Xgeva: Tel Aviv, Israel Thursday, November 27, 2025, 11:00 Hrs [IST ...

Otsuka receives US FDA accelerated approval for Voyxact to reduce proteinuria in adults with IgAN: Princeton, New Jersey Thursday, November 27, 2025, 12:00 Hrs [IST] Otsuka Pharma ...

WHO releases new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs: Geneva Thursday, November 27, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) h ...

AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...

The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and State Governments on matters that require uniform implementation of drug laws across the country, has ...

The Indian Council of Medical Research (ICMR) has released eighth detailed report from the ICMR AMR surveillance network. ICMR has been supporting the Antimicrobial Resistance Research & Surveillance ...

The Karnataka Food and Drugs Administration (FDA) has reaffirmed its uncompromising stance against Not-of-Standard-Quality (NSQ) drugs, declaring that there is absolutely no room for tolerating such ...

DCC stresses on need for uniform implementation of drug standards nationwide: Gireesh Babu, New Delhi Thursday, November 27, 2025, 08:00 Hrs [IST] Alarmed by various issues includ ...

Punjab bars pharmacists from administering injections as IPA pushes national vaccinator training: Peethaambaran Kunnathoor, Chennai Thursday, November 27, 2025, 08:00 Hrs [IST] Th ...

Reuse of single-use medical devices takes center stage at 2025 Medicine & Law Convention, call for India specific regulations: Our Bureau, Bengaluru Wednesday, November 26, 2025, ...

Otsuka submits NDA for centanafadine with US FDA to treat ADHD in children, adolescents and adults: Princeton, New Jersey Wednesday, November 26, 2025, 18:00 Hrs [IST] Otsuka Phar ...